Healthcare provider profile · identity verified

Daniel R Miller, MD

Family Practice · CLARKSVILLE, TN · NPI 1144211871

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	364	105
Atorvastatin Calcium	Atorvastatin Calcium	349	111
Rosuvastatin Calcium	Rosuvastatin Calcium	307	88
Metformin Hcl Er	Metformin Hcl	255	76
Omeprazole	Omeprazole	233	72
Gabapentin	Gabapentin	216	44
Hydrochlorothiazide	Hydrochlorothiazide	214	61
Levothyroxine Sodium	Levothyroxine Sodium	209	57
Amlodipine Besylate	Amlodipine Besylate	181	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	175	32
Metoprolol Succinate	Metoprolol Succinate	164	53
Losartan Potassium	Losartan Potassium	142	43
Fluticasone Propionate	Fluticasone Propionate	141	60
Montelukast Sodium	Montelukast Sodium	141	43
Alprazolam	Alprazolam	130	23
Pantoprazole Sodium	Pantoprazole Sodium	129	42
Tamsulosin Hcl	Tamsulosin Hcl	112	35
Trazodone Hcl	Trazodone Hcl	112	35
Eliquis	Apixaban	111	27
Meloxicam	Meloxicam	107	36
Albuterol Sulfate Hfa	Albuterol Sulfate	106	44
Furosemide	Furosemide	100	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	97	14
Pravastatin Sodium	Pravastatin Sodium	96	30
Simvastatin	Simvastatin	96	28
Famotidine	Famotidine	94	33
Duloxetine Hcl	Duloxetine Hcl	90	24
Telmisartan	Telmisartan	87	24
Allopurinol	Allopurinol	86	25
Nifedipine Er	Nifedipine	86	24
Potassium Chloride	Potassium Chloride	83	28
Alendronate Sodium	Alendronate Sodium	80	22
Carvedilol	Carvedilol	76	26
Metformin Hcl	Metformin Hcl	76	21
Olmesartan Medoxomil	Olmesartan Medoxomil	75	22
Jardiance	Empagliflozin	71	17
Finasteride	Finasteride	66	15
Bupropion Xl	Bupropion Hcl	64	21
Clopidogrel	Clopidogrel Bisulfate	62	19
Ibuprofen	Ibuprofen	62	19
Celecoxib	Celecoxib	59	19
Escitalopram Oxalate	Escitalopram Oxalate	57	15
Fluoxetine Hcl	Fluoxetine Hcl	52	18
Sertraline Hcl	Sertraline Hcl	52	18
Atenolol	Atenolol	50	12
Venlafaxine Hcl Er	Venlafaxine Hcl	50	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	13
Metoprolol Tartrate	Metoprolol Tartrate	47	17
Pregabalin	Pregabalin	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	45	11
Ezetimibe	Ezetimibe	43	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	16
Esomeprazole Magnesium	Esomeprazole Magnesium	41	13
Clonidine Hcl	Clonidine Hcl	40	suppressed
Diazepam	Diazepam	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	11
Xarelto	Rivaroxaban	36	suppressed
Lansoprazole	Lansoprazole	34	suppressed
Ozempic	Semaglutide	33	suppressed
Glipizide Er	Glipizide	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Estradiol	Estradiol	27	11
Quetiapine Fumarate Er	Quetiapine Fumarate	27	suppressed
Spironolactone	Spironolactone	27	11
Tramadol Hcl	Tramadol Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	21
Farxiga	Dapagliflozin Propanediol	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Mupirocin	Mupirocin	23	19
Verapamil Er	Verapamil Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	21	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Prednisone	Prednisone	20	18
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Azithromycin	Azithromycin	18	17
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Clonazepam	Clonazepam	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Trimethoprim	Trimethoprim	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Cefdinir	Cefdinir	12	11
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Naproxen	Naproxen	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Nystatin	Nystatin	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error